through the Integration of Biosensing and AI
Ultra-Precision Sensing Technology
Model BA200
Designed for non-invasive point-of-care assessment of airway inflammation, this device combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results—FeNO, CaNO, FnNO—in under one minute, while a patented dual-channel design ensures complete protection against cross-contamination.
More
Driven by a passion for innovation and a commitment to excellence, desire to maintain high levels of innovation, knowledge, technical expertise, service.
Committed to providing solutions for respiratory diseases, cardiovascular diseases and metabolic diseases
Become a global provider in comprehensive chronic disease solution for both professional segment and homecare.
A pulmonary function report tells you how well air moves in and out of the lungs. A FeNO result tells you something different: how much type 2–driven inflammation is likely present in the airways. When the two are read together, the...
Surgery is supposed to fix a problem, not create a new one in the brain. Yet for some patients—particularly those with chronic obstructive pulmonary disease (COPD)—the days and weeks after an operation can bring a quiet, frust...
Why measuring how you breathe matters—and what the numbers really mean Your lungs are remarkably efficient. At rest, you may take only 12 to 20 breaths per minute, yet those breaths move oxygen into your bloodstream and remove carbo...
Please complete the form to contact our team